{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:00:43Z","timestamp":1779206443882,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T00:00:00Z","timestamp":1567209600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T00:00:00Z","timestamp":1567209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"crossref","award":["RVO 64165"],"award-info":[{"award-number":["RVO 64165"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["Progres Q28\/LF1"],"award-info":[{"award-number":["Progres Q28\/LF1"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["UNCE 204065"],"award-info":[{"award-number":["UNCE 204065"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["SVV 260367"],"award-info":[{"award-number":["SVV 260367"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["EF16_013\/0001674"],"award-info":[{"award-number":["EF16_013\/0001674"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["BBMRI_CZ LM2015089"],"award-info":[{"award-number":["BBMRI_CZ LM2015089"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["CZ.2.16\/3.1.00\/24509"],"award-info":[{"award-number":["CZ.2.16\/3.1.00\/24509"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s12253-019-00739-5","type":"journal-article","created":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T10:40:28Z","timestamp":1567248028000},"page":"1527-1537","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Leiomyoma with Bizarre Nuclei: a Study of 108 Cases Focusing on Clinicopathological Features, Morphology, and Fumarate Hydratase Alterations"],"prefix":"10.1007","volume":"26","author":[{"given":"M\u00e1ria","family":"Gregov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Hojn\u00fd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krist\u00fdna","family":"N\u011bmejcov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela","family":"B\u00e1rt\u016f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"M\u00e1ra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbora","family":"Boudov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Laco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luk\u00e1\u0161","family":"Krbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Tich\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8940-6124","authenticated-orcid":false,"given":"Pavel","family":"Dundr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,31]]},"reference":[{"issue":"6","key":"739_CR1","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/00000478-199406000-00001","volume":"18","author":"SW Bell","year":"1994","unstructured":"Bell SW, Kempson RL, Hendrickson MR (1994) Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol 18(6):535\u2013558","journal-title":"Am J Surg Pathol"},{"key":"739_CR2","volume-title":"WHO Classification of tumours of female reproductive organs","author":"RJ Kurman","year":"2014","unstructured":"Kurman RJ, Carcangiu ML, Young RH, Herrington CSE (2014) WHO Classification of tumours of female reproductive organs, 4th edn. IARC, Lyon:307","edition":"4"},{"issue":"10","key":"739_CR3","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/modpathol.2016.107","volume":"29","author":"B Liegl-Atzwanger","year":"2016","unstructured":"Liegl-Atzwanger B, Heitzer E, Flicker K, Muller S, Ulz P, Saglam O, Tavassoli F, Devouassoux-Shisheboran M, Geigl J, Moinfar F (2016) Exploring chromosomal abnormalities and genetic changes in uterine smooth muscle tumors. Mod Pathol 29(10):1262\u20131277. \nhttps:\/\/doi.org\/10.1038\/modpathol.2016.107","journal-title":"Mod Pathol"},{"issue":"1","key":"739_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12943-017-0672-1","volume":"16","author":"N Makinen","year":"2017","unstructured":"Makinen N, Kampjarvi K, Frizzell N, Butzow R, Vahteristo P (2017) Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors. Mol Cancer 16(1):101. \nhttps:\/\/doi.org\/10.1186\/s12943-017-0672-1","journal-title":"Mol Cancer"},{"issue":"7","key":"739_CR5","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1097\/PAS.0000000000000646","volume":"40","author":"JM Ubago","year":"2016","unstructured":"Ubago JM, Zhang Q, Kim JJ, Kong B, Wei JJ (2016) Two subtypes of atypical Leiomyoma: clinical, histologic, and molecular analysis. Am J Surg Pathol 40(7):923\u2013933. \nhttps:\/\/doi.org\/10.1097\/PAS.0000000000000646","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"739_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/gcc.2870020103","volume":"2","author":"M Nibert","year":"1990","unstructured":"Nibert M, Heim S (1990) Uterine leiomyoma cytogenetics. Genes Chromosomes Cancer 2(1):3\u201313","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"739_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0002-9440(10)63091-X","volume":"164","author":"R Lehtonen","year":"2004","unstructured":"Lehtonen R, Kiuru M, Vanharanta S, Sjoberg J, Aaltonen LM, Aittomaki K, Arola J, Butzow R, Eng C, Husgafvel-Pursiainen K, Isola J, Jarvinen H, Koivisto P, Mecklin JP, Peltomaki P, Salovaara R, Wasenius VM, Karhu A, Launonen V, Nupponen NN, Aaltonen LA (2004) Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors. Am J Pathol 164(1):17\u201322. \nhttps:\/\/doi.org\/10.1016\/S0002-9440(10)63091-X","journal-title":"Am J Pathol"},{"issue":"5","key":"739_CR8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/PAS.0000000000000573","volume":"40","author":"WJ Harrison","year":"2016","unstructured":"Harrison WJ, Andrici J, Maclean F, Madadi-Ghahan R, Farzin M, Sioson L, Toon CW, Clarkson A, Watson N, Pickett J, Field M, Crook A, Tucker K, Goodwin A, Anderson L, Srinivasan B, Grossmann P, Martinek P, Ondic O, Hes O, Trpkov K, Clifton-Bligh RJ, Dwight T, Gill AJ (2016) Fumarate hydratase-deficient uterine leiomyomas occur in both the syndromic and sporadic settings. Am J Surg Pathol 40(5):599\u2013607. \nhttps:\/\/doi.org\/10.1097\/PAS.0000000000000573","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"739_CR9","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/ijc.21798","volume":"119","author":"SK Ylisaukko-oja","year":"2006","unstructured":"Ylisaukko-oja SK, Kiuru M, Lehtonen HJ, Lehtonen R, Pukkala E, Arola J, Launonen V, Aaltonen LA (2006) Analysis of fumarate hydratase mutations in a population-based series of early onset uterine leiomyosarcoma patients. Int J Cancer 119(2):283\u2013287. \nhttps:\/\/doi.org\/10.1002\/ijc.21798","journal-title":"Int J Cancer"},{"issue":"1","key":"739_CR10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.canlet.2005.04.017","volume":"235","author":"KT Barker","year":"2006","unstructured":"Barker KT, Spendlove HE, Banu NS, Bridge JA, Fisher C, Shipley J, Garrett M, Manyonda I, Houlston RS (2006) No evidence for epigenetic inactivation of fumarate hydratase in leiomyomas and leiomyosarcomas. Cancer Lett 235(1):136\u2013140. \nhttps:\/\/doi.org\/10.1016\/j.canlet.2005.04.017","journal-title":"Cancer Lett"},{"issue":"4","key":"739_CR11","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S1525-1578(10)60574-0","volume":"7","author":"NA Alam","year":"2005","unstructured":"Alam NA, Olpin S, Rowan A, Kelsell D, Leigh IM, Tomlinson IP, Weaver T (2005) Missense mutations in fumarate hydratase in multiple cutaneous and uterine leiomyomatosis and renal cell cancer. J Mol Diagn 7(4):437\u2013443. \nhttps:\/\/doi.org\/10.1016\/S1525-1578(10)60574-0","journal-title":"J Mol Diagn"},{"issue":"12","key":"739_CR12","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1097\/DAD.0000000000000580","volume":"38","author":"M Llamas-Velasco","year":"2016","unstructured":"Llamas-Velasco M, Requena L, Adam J, Frizzell N, Hartmann A, Mentzel T (2016) Loss of fumarate hydratase and aberrant protein succination detected with S-(2-Succino)-cysteine staining to identify patients with Multiple cutaneous and uterine Leiomyomatosis and hereditary Leiomyomatosis and renal cell cancer syndrome. Am J Dermatopathol 38(12):887\u2013891. \nhttps:\/\/doi.org\/10.1097\/DAD.0000000000000580","journal-title":"Am J Dermatopathol"},{"issue":"6","key":"739_CR13","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/PGP.0000000000000276","volume":"35","author":"JJ Wei","year":"2016","unstructured":"Wei JJ (2016) Atypical leiomyoma with features suggesting of fumarate hydratase mutation. Int J Gynecol Pathol 35(6):531\u2013536. \nhttps:\/\/doi.org\/10.1097\/PGP.0000000000000276","journal-title":"Int J Gynecol Pathol"},{"issue":"13","key":"739_CR14","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1158\/1078-0432.CCR-13-0304","volume":"19","author":"WM Linehan","year":"2013","unstructured":"Linehan WM, Rouault TA (2013) Molecular pathways: fumarate hydratase-deficient kidney cancer--targeting the Warburg effect in cancer. Clin Cancer Res 19(13):3345\u20133352. \nhttps:\/\/doi.org\/10.1158\/1078-0432.CCR-13-0304","journal-title":"Clin Cancer Res"},{"issue":"3","key":"739_CR15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ccr.2011.07.018","volume":"20","author":"WH Tong","year":"2011","unstructured":"Tong WH, Sourbier C, Kovtunovych G, Jeong SY, Vira M, Ghosh M, Romero VV, Sougrat R, Vaulont S, Viollet B, Kim YS, Lee S, Trepel J, Srinivasan R, Bratslavsky G, Yang Y, Linehan WM, Rouault TA (2011) The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels. Cancer Cell 20(3):315\u2013327. \nhttps:\/\/doi.org\/10.1016\/j.ccr.2011.07.018","journal-title":"Cancer Cell"},{"issue":"4","key":"739_CR16","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/ng849","volume":"30","author":"IP Tomlinson","year":"2002","unstructured":"Tomlinson IP, Alam NA, Rowan AJ, Barclay E, Jaeger EE, Kelsell D, Leigh I, Gorman P, Lamlum H, Rahman S, Roylance RR, Olpin S, Bevan S, Barker K, Hearle N, Houlston RS, Kiuru M, Lehtonen R, Karhu A, Vilkki S, Laiho P, Eklund C, Vierimaa O, Aittomaki K, Hietala M, Sistonen P, Paetau A, Salovaara R, Herva R, Launonen V, Aaltonen LA, Multiple Leiomyoma C (2002) Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 30(4):406\u2013410. \nhttps:\/\/doi.org\/10.1038\/ng849","journal-title":"Nat Genet"},{"issue":"7","key":"739_CR17","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1097\/PAS.0000000000000617","volume":"40","author":"K Trpkov","year":"2016","unstructured":"Trpkov K, Hes O, Agaimy A, Bonert M, Martinek P, Magi-Galluzzi C, Kristiansen G, Luders C, Nesi G, Comperat E, Sibony M, Berney DM, Mehra R, Brimo F, Hartmann A, Husain A, Frizzell N, Hills K, Maclean F, Srinivasan B, Gill AJ (2016) Fumarate hydratase-deficient renal cell carcinoma is strongly correlated with fumarate hydratase mutation and hereditary leiomyomatosis and renal cell carcinoma syndrome. Am J Surg Pathol 40(7):865\u2013875. \nhttps:\/\/doi.org\/10.1097\/PAS.0000000000000617","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"739_CR18","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1097\/PAS.0000000000000626","volume":"40","author":"B Buelow","year":"2016","unstructured":"Buelow B, Cohen J, Nagymanyoki Z, Frizzell N, Joseph NM, McCalmont T, Garg K (2016) Immunohistochemistry for 2-Succinocysteine (2SC) and Fumarate Hydratase (FH) in cutaneous leiomyomas may aid in identification of patients with HLRCC (Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome). Am J Surg Pathol 40(7):982\u2013988. \nhttps:\/\/doi.org\/10.1097\/PAS.0000000000000626","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"739_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/jmg.2005.033506","volume":"43","author":"MH Wei","year":"2006","unstructured":"Wei MH, Toure O, Glenn GM, Pithukpakorn M, Neckers L, Stolle C, Choyke P, Grubb R, Middelton L, Turner ML, Walther MM, Merino MJ, Zbar B, Linehan WM, Toro JR (2006) Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet 43(1):18\u201327. \nhttps:\/\/doi.org\/10.1136\/jmg.2005.033506","journal-title":"J Med Genet"},{"issue":"1","key":"739_CR20","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GR, Thormann A, Flicek P, Cunningham F (2016) The Ensembl variant effect predictor. Genome Biol 17(1):122. \nhttps:\/\/doi.org\/10.1186\/s13059-016-0974-4","journal-title":"Genome Biol"},{"issue":"10","key":"739_CR21","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1038\/modpathol.2017.56","volume":"30","author":"JA Bennett","year":"2017","unstructured":"Bennett JA, Weigelt B, Chiang S, Selenica P, Chen YB, Bialik A, Bi R, Schultheis AM, Lim RS, Ng CKY, Morales-Oyarvide V, Young RH, Reuter VE, Soslow RA, Oliva E (2017) Leiomyoma with bizarre nuclei: a morphological, immunohistochemical and molecular analysis of 31 cases. Mod Pathol 30(10):1476\u20131488. \nhttps:\/\/doi.org\/10.1038\/modpathol.2017.56","journal-title":"Mod Pathol"},{"issue":"10","key":"739_CR22","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1097\/PAS.0000000000000249","volume":"38","author":"S Croce","year":"2014","unstructured":"Croce S, Young RH, Oliva E (2014) Uterine leiomyomas with bizarre nuclei: a clinicopathologic study of 59 cases. Am J Surg Pathol 38(10):1330\u20131339. \nhttps:\/\/doi.org\/10.1097\/PAS.0000000000000249","journal-title":"Am J Surg Pathol"},{"issue":"Suppl 1","key":"739_CR23","doi-asserted-by":"publisher","first-page":"683","DOI":"10.15171\/apb.2015.093","volume":"5","author":"A Dastranj Tabrizi","year":"2015","unstructured":"Dastranj Tabrizi A, Ghojazadeh M, Thagizadeh Anvar H, Vahedi A, Naji S, Mostafidi E, Berenjian S (2015) Immunohistochemical profile of uterine leiomyoma with bizarre nuclei; comparison with conventional leiomyoma, smooth muscle tumors of uncertain malignant potential and leiomyosarcoma. Adv Pharm Bull 5(Suppl 1):683\u2013687. \nhttps:\/\/doi.org\/10.15171\/apb.2015.093","journal-title":"Adv Pharm Bull"},{"key":"739_CR24","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/PGP.0000000000000425","volume":"37","author":"M Kefeli","year":"2017","unstructured":"Kefeli M, Caliskan S, Kurtoglu E, Yildiz L, Kokcu A (2017) Leiomyoma with bizarre nuclei: clinical and pathologic features of 30 patients. Int J Gynecol Pathol 37:379\u2013387. \nhttps:\/\/doi.org\/10.1097\/PGP.0000000000000425","journal-title":"Int J Gynecol Pathol"},{"issue":"6","key":"739_CR25","first-page":"7196","volume":"8","author":"Y Liang","year":"2015","unstructured":"Liang Y, Zhang X, Chen X, Lu W (2015) Diagnostic value of progesterone receptor, p16, p53 and pHH3 expression in uterine atypical leiomyoma. Int J Clin Exp Pathol 8(6):7196\u20137202","journal-title":"Int J Clin Exp Pathol"},{"issue":"5","key":"739_CR26","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/PAS.0b013e3182893f36","volume":"37","author":"A Ly","year":"2013","unstructured":"Ly A, Mills AM, McKenney JK, Balzer BL, Kempson RL, Hendrickson MR, Longacre TA (2013) Atypical leiomyomas of the uterus: a clinicopathologic study of 51 cases. Am J Surg Pathol 37(5):643\u2013649. \nhttps:\/\/doi.org\/10.1097\/PAS.0b013e3182893f36","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"739_CR27","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1097\/PGP.0b013e3181a2b8d3","volume":"28","author":"CO Sung","year":"2009","unstructured":"Sung CO, Ahn G, Song SY, Choi YL, Bae DS (2009) Atypical leiomyomas of the uterus with long-term follow-up after myomectomy with immunohistochemical analysis for p16INK4A, p53, Ki-67, estrogen receptors, and progesterone receptors. Int J Gynecol Pathol 28(6):529\u2013534. \nhttps:\/\/doi.org\/10.1097\/PGP.0b013e3181a2b8d3","journal-title":"Int J Gynecol Pathol"},{"key":"739_CR28","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/PGP.0000000000000447","volume":"37","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Poropatich K, Ubago J, Xie J, Xu X, Frizzell N, Kim J, Kong B, Wei JJ (2017) Fumarate hydratase mutations and alterations in Leiomyoma with bizarre nuclei. Int J Gynecol Pathol 37:421\u2013430. \nhttps:\/\/doi.org\/10.1097\/PGP.0000000000000447","journal-title":"Int J Gynecol Pathol"},{"issue":"2","key":"739_CR29","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.3892\/ol.2015.4062","volume":"11","author":"I Kalogiannidis","year":"2016","unstructured":"Kalogiannidis I, Stavrakis T, Dagklis T, Petousis S, Nikolaidou C, Venizelos I, Rousso D (2016) A clinicopathological study of atypical leiomyomas: benign variant leiomyoma or smooth-muscle tumor of uncertain malignant potential. Oncol Lett 11(2):1425\u20131428. \nhttps:\/\/doi.org\/10.3892\/ol.2015.4062","journal-title":"Oncol Lett"},{"issue":"5","key":"739_CR30","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1097\/PAS.0b013e318287779c","volume":"37","author":"AM Mills","year":"2013","unstructured":"Mills AM, Ly A, Balzer BL, Hendrickson MR, Kempson RL, McKenney JK, Longacre TA (2013) Cell cycle regulatory markers in uterine atypical leiomyoma and leiomyosarcoma: immunohistochemical study of 68 cases with clinical follow-up. Am J Surg Pathol 37(5):634\u2013642. \nhttps:\/\/doi.org\/10.1097\/PAS.0b013e318287779c","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"739_CR31","first-page":"4418","volume":"8","author":"SJ Pang","year":"2015","unstructured":"Pang SJ, Li CC, Shen Y, Liu YZ, Shi YQ, Liu YX (2015) Value of counting positive PHH3 cells in the diagnosis of uterine smooth muscle tumors. Int J Clin Exp Pathol 8(5):4418\u20134426","journal-title":"Int J Clin Exp Pathol"},{"issue":"3","key":"739_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.prp.2006.12.008","volume":"203","author":"P Dundr","year":"2007","unstructured":"Dundr P, Povysil C, Tvrdik D, Mara M (2007) Uterine leiomyomas with inclusion bodies: an immunohistochemical and ultrastructural analysis of 12 cases. Pathol Res Pract 203(3):145\u2013151. \nhttps:\/\/doi.org\/10.1016\/j.prp.2006.12.008","journal-title":"Pathol Res Pract"},{"issue":"11","key":"739_CR33","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/ejhg.2013.33","volume":"21","author":"N Makinen","year":"2013","unstructured":"Makinen N, Vahteristo P, Kampjarvi K, Arola J, Butzow R, Aaltonen LA (2013) MED12 exon 2 mutations in histopathological uterine leiomyoma variants. Eur J Hum Genet 21(11):1300\u20131303. \nhttps:\/\/doi.org\/10.1038\/ejhg.2013.33","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"739_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005850","volume":"12","author":"N Makinen","year":"2016","unstructured":"Makinen N, Aavikko M, Heikkinen T, Taipale M, Taipale J, Koivisto-Korander R, Butzow R, Vahteristo P (2016) Exome sequencing of uterine leiomyosarcomas identifies frequent mutations in TP53, ATRX, and MED12. PLoS Genet 12(2):e1005850. \nhttps:\/\/doi.org\/10.1371\/journal.pgen.1005850","journal-title":"PLoS Genet"},{"issue":"7","key":"739_CR35","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/modpathol.2013.215","volume":"27","author":"C Reyes","year":"2014","unstructured":"Reyes C, Karamurzin Y, Frizzell N, Garg K, Nonaka D, Chen YB, Soslow RA (2014) Uterine smooth muscle tumors with features suggesting fumarate hydratase aberration: detailed morphologic analysis and correlation with S-(2-succino)-cysteine immunohistochemistry. Mod Pathol 27(7):1020\u20131027. \nhttps:\/\/doi.org\/10.1038\/modpathol.2013.215","journal-title":"Mod Pathol"},{"issue":"1","key":"739_CR36","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/PAS.0b013e31825ec16f","volume":"37","author":"J Sanz-Ortega","year":"2013","unstructured":"Sanz-Ortega J, Vocke C, Stratton P, Linehan WM, Merino MJ (2013) Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome. Am J Surg Pathol 37(1):74\u201380. \nhttps:\/\/doi.org\/10.1097\/PAS.0b013e31825ec16f","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"739_CR37","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1097\/PAS.0000000000000520","volume":"39","author":"NM Joseph","year":"2015","unstructured":"Joseph NM, Solomon DA, Frizzell N, Rabban JT, Zaloudek C, Garg K (2015) Morphology and immunohistochemistry for 2SC and FH aid in detection of fumarate hydratase gene aberrations in uterine leiomyomas from young patients. Am J Surg Pathol 39(11):1529\u20131539. \nhttps:\/\/doi.org\/10.1097\/PAS.0000000000000520","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"739_CR38","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1097\/PAS.0000000000000703","volume":"40","author":"M Miettinen","year":"2016","unstructured":"Miettinen M, Felisiak-Golabek A, Wasag B, Chmara M, Wang Z, Butzow R, Lasota J (2016) Fumarase-deficient uterine leiomyomas: an immunohistochemical, molecular genetic, and clinicopathologic study of 86 cases. Am J Surg Pathol 40(12):1661\u20131669. \nhttps:\/\/doi.org\/10.1097\/PAS.0000000000000703","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"739_CR39","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s10545-011-9294-8","volume":"34","author":"S Picaud","year":"2011","unstructured":"Picaud S, Kavanagh KL, Yue WW, Lee WH, Muller-Knapp S, Gileadi O, Sacchettini J, Oppermann U (2011) Structural basis of fumarate hydratase deficiency. J Inherit Metab Dis 34(3):671\u2013676. \nhttps:\/\/doi.org\/10.1007\/s10545-011-9294-8","journal-title":"J Inherit Metab Dis"},{"issue":"3 Pt 1","key":"739_CR40","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.jaad.2004.08.051","volume":"52","author":"GS Chuang","year":"2005","unstructured":"Chuang GS, Martinez-Mir A, Geyer A, Engler DE, Glaser B, Cserhalmi-Friedman PB, Gordon D, Horev L, Lukash B, Herman E, Cid MP, Brenner S, Landau M, Sprecher E, Garcia Muret MP, Christiano AM, Zlotogorski A (2005) Germline fumarate hydratase mutations and evidence for a founder mutation underlying multiple cutaneous and uterine leiomyomata. J Am Acad Dermatol 52(3 Pt 1):410\u2013416. \nhttps:\/\/doi.org\/10.1016\/j.jaad.2004.08.051","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"739_CR41","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00428-018-2292-6","volume":"472","author":"L Siegler","year":"2018","unstructured":"Siegler L, Erber R, Burghaus S, Brodkorb T, Wachter D, Wilkinson N, Bolton J, Stringfellow H, Haller F, Beckmann MW, Hartmann A, Agaimy A (2018) Fumarate hydratase (FH) deficiency in uterine leiomyomas: recognition by histological features versus blind immunoscreening. Virchows Arch 472(5):789\u2013796. \nhttps:\/\/doi.org\/10.1007\/s00428-018-2292-6","journal-title":"Virchows Arch"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-019-00739-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-019-00739-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-019-00739-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T23:17:43Z","timestamp":1598743063000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-019-00739-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,31]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["739"],"URL":"https:\/\/doi.org\/10.1007\/s12253-019-00739-5","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,31]]},"assertion":[{"value":"20 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In compliance with the Helsinki Declaration, the project has been approved by Ethics Committee of the General University Hospital, Prague (reference number \u010d.j. 98\/16 Grant RVO-VFN 64165).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}